CIB-1476, a caspase-1 inhibitor, effectively reduces joint swelling in mouse models of arthritis and demonstrates lasting anti-inflammatory effects. This compound achieves its benefits by blocking IL-1beta production, NF-kappaB activation, and GSDMD-mediated pyroptosis, all of which are triggered by the NLRP3 inflammasome.
